Varela Ignacio, Menendez Pablo, Sanjuan-Pla Alejandra
Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria-CSIC, Santander, Spain.
Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.
Oncotarget. 2017 Aug 16;8(39):66742-66746. doi: 10.18632/oncotarget.20279. eCollection 2017 Sep 12.
This meeting held at the University of Barcelona in March 2017, brought together scientists and clinicians worldwide to discuss current and future clinico-biological implications of intratumoral heterogeneity (ITH) and subclonal evolution in cancer diagnosis, patient stratification, and treatment resistance in diagnosis, treatment and follow-up. There was consensus that both longitudinal and tumor multi-region studies in matched samples are needed to better understand the dynamics of ITH. The contribution of the epigenome and microenvironment to ITH and subclone evolution remains understudied. It was recommended to combine computational, pathology and imaging tools to study the role of the microenvironment in subclone selection/evolution.
2017年3月在巴塞罗那大学召开的本次会议,汇聚了全球的科学家和临床医生,共同探讨肿瘤内异质性(ITH)和亚克隆进化在癌症诊断、患者分层以及诊断、治疗和随访中的治疗抵抗方面的当前及未来临床生物学意义。与会者达成共识,认为需要对匹配样本进行纵向和肿瘤多区域研究,以更好地理解ITH的动态变化。表观基因组和微环境对ITH及亚克隆进化的作用仍未得到充分研究。会议建议结合计算、病理学和成像工具,研究微环境在亚克隆选择/进化中的作用。